Oluyemi Komolafe et al.
The Cochrane database of systematic reviews, 7, CD013157-CD013157 (2021-07-20)
The prevalence of non-alcohol-related fatty liver disease (NAFLD) varies between 19% and 33% in different populations. NAFLD decreases life expectancy and increases risks of liver cirrhosis, hepatocellular carcinoma, and the requirement for liver transplantation. Uncertainty surrounds relative benefits and harms